Related references
Note: Only part of the references are listed.Clinical Pharmacokinetics and Pharmacodynamics of Naloxegol, a Peripherally Acting μ-Opioid Receptor Antagonist
Khanh Bui et al.
CLINICAL PHARMACOKINETICS (2017)
Economic and clinical burden of opioid-induced nausea and vomiting
Bruce D. Nicholson
POSTGRADUATE MEDICINE (2017)
Pharmacologic Profile of Naloxegol, a Peripherally Acting μ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation
Eike Floettmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Peripherally acting μ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy
Joseph V. Pergolizzi et al.
PATIENT PREFERENCE AND ADHERENCE (2017)
Relationship of gastric emptying or accommodation with satiation, satiety, and postprandial symptoms in health
Houssam Halawi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)
Opioid-induced bowel dysfunction in healthy volunteers assessed with questionnaires and MRI
Matias Nilsson et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)
The Impact of Opioid Treatment on Regional Gastrointestinal Transit
Jakob L. Poulsen et al.
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY (2016)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Naloxegol at Peripheral and Central Nervous System Receptors in Healthy Male Subjects: A Single Ascending-Dose Study
Michael A. Eldon et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2015)
The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health
B. S. Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain
Lynn Webster et al.
PAIN (2008)
Effect of alvimopan and codeine on gastrointestinal transit: A randomized controlled study
J Gonenne et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Irritable bowel syndrome patients show altered sensitivity to exogenous opioids
T Lembo et al.
PAIN (2000)